Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Spitzer

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|July 1, 1991
Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levelsM Cottler-Fox, M Lynch, L W Pickle, et al.
Bone Marrow Transplantation|October 12, 1999
Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantationH C Toh, S L McAfee, R Sackstein, et al.
Bone Marrow Transplantation|September 1, 1989
Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantationT R Spitzer, M Cottler-Fox, J Torrisi, et al.
Bone Marrow Transplantation|March 1, 1989
Pulmonary fibrosis after bone marrow transplantation responsive to treatment with prednisone and cyclosporineJ W Raschko, M Cottler-Fox, S L Abbondanzo, et al.
Psychosomatic Medicine|April 30, 1998
A comparison of related and unrelated marrow donorsG Chang, C McGarigle, T R Spitzer, et al.
Bone Marrow Transplantation|February 2, 2000
Decreased graft-versus-host disease after haplotype mismatched bone marrow allografts in miniature swine following interleukin-2 treatmentT Kozlowski, T Sablinski, M Basker, et al.
Cancer Treatment Reports|May 1, 1985
Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantationH M Lazarus, R H Herzig, S N Wolff, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
In vitro and in vivo effects of recombinant human interleukin-2 in naive miniature swineK Nakajima, C V Smith, A Mixon, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1994
Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and childrenT R Spitzer, C Peters, M Ortlieb, et al.
Bone Marrow Transplantation|February 2, 2000
High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II studyH C Toh, S L McAfee, R Sackstein, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|July 1, 1991
Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levelsM Cottler-Fox, M Lynch, L W Pickle, et al.
Bone Marrow Transplantation|October 12, 1999
Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantationH C Toh, S L McAfee, R Sackstein, et al.
Bone Marrow Transplantation|September 1, 1989
Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantationT R Spitzer, M Cottler-Fox, J Torrisi, et al.
Bone Marrow Transplantation|March 1, 1989
Pulmonary fibrosis after bone marrow transplantation responsive to treatment with prednisone and cyclosporineJ W Raschko, M Cottler-Fox, S L Abbondanzo, et al.
Psychosomatic Medicine|April 30, 1998
A comparison of related and unrelated marrow donorsG Chang, C McGarigle, T R Spitzer, et al.
Bone Marrow Transplantation|February 2, 2000
Decreased graft-versus-host disease after haplotype mismatched bone marrow allografts in miniature swine following interleukin-2 treatmentT Kozlowski, T Sablinski, M Basker, et al.
Cancer Treatment Reports|May 1, 1985
Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantationH M Lazarus, R H Herzig, S N Wolff, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
In vitro and in vivo effects of recombinant human interleukin-2 in naive miniature swineK Nakajima, C V Smith, A Mixon, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1994
Etoposide in combination with cyclophosphamide and total body irradiation or busulfan as conditioning for marrow transplantation in adults and childrenT R Spitzer, C Peters, M Ortlieb, et al.
Bone Marrow Transplantation|February 2, 2000
High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II studyH C Toh, S L McAfee, R Sackstein, et al.
Pageof 9